. 2005 Aug 9;112(6):906-15; discussion 923.
doi: 10.1161/CIRCULATIONAHA.104.483297.
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes
Affiliations
- PMID: 16087811
- DOI: 10.1161/CIRCULATIONAHA.104.483297
Item in Clipboard
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes
Circulation.
.
No abstract available
Similar articles
-
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes.Circulation. 2005 Aug 9;112(6):916-22; discussion 922. Circulation. 2005. PMID: 16092153 No abstract available.
-
Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.J Invasive Cardiol. 2008 Mar;20(3):108-12. J Invasive Cardiol. 2008. PMID: 18316825
-
Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR).J Am Coll Cardiol. 2008 May 27;51(21):2068-74. doi: 10.1016/j.jacc.2008.01.054. J Am Coll Cardiol. 2008. PMID: 18498965 No abstract available.
-
Prognostic significance of creatine kinase release after percutaneous coronary intervention.Ital Heart J. 2005 Jun;6(6):522-9. Ital Heart J. 2005. PMID: 16008158 Review.
-
[Diagnostic and prognostic significance of CK-MB, troponins, CRP, BNP and/or NT-proBNP in coronary angioplasty. Elevation mechanisms and clinical implications].Arch Mal Coeur Vaiss. 2007 Nov;100(11):925-33. Arch Mal Coeur Vaiss. 2007. PMID: 18209693 Review. French.
Cited by
-
Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials.Int J Cardiol. 2018 Nov 1;270:96-101. doi: 10.1016/j.ijcard.2018.06.034. Epub 2018 Jun 8. Int J Cardiol. 2018. PMID: 29937301 Free PMC article. Clinical Trial.
-
Use of a Cutting Balloon Reduces the Incidence of Distal Embolism in Acute Coronary Syndrome Requiring Predilatation Before Stenting.Circ Rep. 2022 Jul 9;4(8):345-352. doi: 10.1253/circrep.CR-22-0056. eCollection 2022 Aug 10. Circ Rep. 2022. PMID: 36032387 Free PMC article.
-
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).Circulation. 2016 Sep 6;134(10):723-33. doi: 10.1161/CIRCULATIONAHA.115.020829. Epub 2016 Aug 1. Circulation. 2016. PMID: 27482008 Free PMC article. Clinical Trial.
-
Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial.Clin Res Cardiol. 2011 Aug;100(8):691-9. doi: 10.1007/s00392-011-0299-y. Epub 2011 Mar 8. Clin Res Cardiol. 2011. PMID: 21384174 Clinical Trial.
-
A randomized study assessing the effects of pretreatment with cilostazol on periprocedural myonecrosis after percutaneous coronary intervention.Yonsei Med J. 2011 Sep;52(5):717-26. doi: 10.3349/ymj.2011.52.5.717. Yonsei Med J. 2011. PMID: 21786434 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
